RC
TMO icon

Rovin Capital’s Thermo Fisher Scientific TMO Stock Holding History

Rovin Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$843K Buy
1,454
+551
+61% +$312K 0.22% 82
2025
Q3 		$438K Buy
903
+83
+10% +$38.6K 0.12% 130
2025
Q2 		$332K Buy
820
+101
+14% +$42.2K 0.1% 151
2025
Q1 		$358K Buy
719
+116
+19% +$62.8K 0.12% 136
2024
Q4 		$314K Sell
603
-65
-10% -$35.7K 0.11% 127
2024
Q3 		$413K Buy
668
+39
+6% +$23.1K 0.15% 115
2024
Q2 		$348K Buy
629
+70
+13% +$40.1K 0.15% 117
2024
Q1 		$325K Buy
+559
New +$314K 0.13% 115
2022
Q2 		– Sell
-346
Closed -$204K – 129
2022
Q1 		$204K Sell
346
-615
-64% -$353K 0.11% 116
2021
Q4 		$641K Buy
961
+603
+168% +$376K 0.31% 51
2021
Q3 		$205K Buy
+358
New +$196K 0.14% 62

Other funds holding TMO

JSC
J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Rovin Capital's TMO Position: Q4 2025 in Review

Rovin Capital increased its Thermo Fisher Scientific (TMO) stake by 61% in Q4 2025, buying an estimated $312K and bringing the position to 1,454 shares worth $843K. The position accounts for 0.22% of the portfolio, ranked #82.

Rovin Capital first reported a position in TMO in Q3 2021 and has held it in 11 quarters since. 2,699 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

  • Rovin Capital held 1,454 shares of Thermo Fisher Scientific worth $843K as of Q4 2025.
  • Rovin Capital bought 551 Thermo Fisher Scientific shares in Q4 2025, an estimated $312K.
  • Thermo Fisher Scientific made up 0.22% of Rovin Capital's portfolio in Q4 2025, its #82 holding.
  • Rovin Capital first reported a position in Thermo Fisher Scientific in Q3 2021 and has held it in 11 quarters since.
  • 2,699 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on Rovin Capital's 13F filing for Q4 2025, filed 9 Feb 2026.